Survival In Today's Tight Funding Climate Depends On Following Agencies' Rules

Depends On Following Agencies' Rules Securing research support increasingly occupies the time and energy of academic scientists. As a program officer with a private foundation supporting biomedical, behavioral, and educational research, I am experiencing first-hand how the shrinking supply of federal funding dollars is driving more and more investigators to the terre incognito of private foundation funding. Recently, The Scientist provided some tips on how to improve the chances of a submissio

Written bySusan Fitzpatrick
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Depends On Following Agencies' Rules Susan Fitzpatrick Securing research support increasingly occupies the time and energy of academic scientists. As a program officer with a private foundation supporting biomedical, behavioral, and educational research, I am experiencing first-hand how the shrinking supply of federal funding dollars is driving more and more investigators to the terre incognito of private foundation funding. Recently, The Scientist provided some tips on how to improve the chances of a submission to federal funding agencies (L. Reif-Lehrer, March 4, 1996, page 15). In reality, the "rules" for approaching private funding sources are quite similar-all instructions must be scrupulously followed if a proposal is to receive serious consideration.

Attention to detail is essential; many private foundations operate with small staffs wearing multiple hats. Program officers typically manage several programs, and often they have subject-matter expertise in some, but not all, of the programmatic disciplines. Although officers become adept at reviewing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies